Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
Carolina Tiraboschi, Lucas D. Gentilini, Carla Velazquez, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001535-e001535
Open Access | Times Cited: 15

Showing 15 citing articles:

Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 137
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 41
Astragalus polysaccharide ameliorates CD8+ T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation‐induced colorectal cancer
Qiuyi Li, Chonghao Zhang, Guichuan Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116172-116172
Open Access | Times Cited: 14
Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
Nikiforos-Ioannis Kapetanakis, Pierre Busson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 5
Inhibition of galectins in cancer: Biological challenges for their clinical application
Diego J. Laderach, Daniel Compagno
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 12
Editorial: Galectins and hormones in health and disease
María F. Troncoso, Roger Chammas, Vinícius F. Carvalho, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Galectin-3 suppresses CD8+ T cells function via myeloid-derived suppressor cells recruitment in cervical cancer
Qiuwen Mai, Qiqiao Du, Feitianzhi Zeng, et al.
International Journal of Biological Macromolecules (2025), pp. 143683-143683
Closed Access
Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor
Deborah Simão Souza, Carla Macheroni, Gustavo J.S. Pereira, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Targeting the ATF6-Mediated ER Stress Response and Autophagy Blocks Integrin-Driven Prostate Cancer Progression
Amanda J. Macke, Artem N. Pachikov, Taylor E. Divita, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 958-974
Open Access | Times Cited: 9
Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1
Deqin Cai, Fei He, Shengjie Wu, et al.
Carbohydrate Polymers (2023) Vol. 327, pp. 121668-121668
Closed Access | Times Cited: 8
Antibody-lectin chimeras for glyco-immune checkpoint blockade
Jessica C. Stark, Melissa A. Gray, Simon Wisnovsky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
Diego J. Laderach, Daniel Compagno
Cancers (2021) Vol. 13, Iss. 18, pp. 4529-4529
Open Access | Times Cited: 14
Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers
Tânia Lima, Rita Ferreira, Marina Corrêa Freitas, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 2, pp. 447-458
Closed Access | Times Cited: 9
Targeting galectins in T cell-based immunotherapy within tumor microenvironment
Qiuyang Jin, Yingshuang Li, Xing-Hui Qiao, et al.
Life Sciences (2021) Vol. 277, pp. 119426-119426
Closed Access | Times Cited: 9
Hubungan antara ekspresi Galectin 3 dengan stadium FIGO pada karsinoma sel skuamosa serviks uteri di RSUP Prof. dr. I.G.N.G. Ngoerah Denpasar
Mellinda Wijaya, Ni Wayan Winarti, I Gusti Ayu Sri Mahendra Dewi, et al.
Intisari Sains Medis (2023) Vol. 14, Iss. 1, pp. 143-148
Open Access
Page 1

Scroll to top